Lilly and Parexel Partner on Asia-Pacific Clinical Trials

Eli Lilly has partnered with Parexel, a global CRO based in the US, to support its clinical trials in the Asia-Pacific region. Parexel will be given the job of assisting Lilly in Asia and Australia with clinical trial start-up and site monitoring. Lilly has followed a partnership approach on its R&D work in China, and now it has implemented a similar model for conducting clinical trials. More details.... Stock Symbols: (NYSE LLY)  (NSDQ: PRXL)